225 pipelines of biologics being developed in Korea

Published: 2017-09-22 15:05:36

Updated: 2017-09-22 15:05:36

There were reportedly 225 cases of clinical trials for biologics being developed in Korea.

According to the Ministry of Food and Drug Safety(MFDS), there were ongoing clinical trials for total 225 products at the end of 2016: 151 generic recombinant medicines, 33 cell therapies, 32 biologics and 9 gene therapies.

The MFDS said a number of products in the fields where Korea is currently leadin...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.